BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35087764)

  • 1. Retraction: LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840907. PubMed ID: 35087764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer
    Zhao GY; Ning ZF; Wang R
    Front Oncol; 2021; 11():630241. PubMed ID: 33842336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():841478. PubMed ID: 35036363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction: LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration
    Frontiers Editorial Office
    Front Oncol; 2022; 12():858846. PubMed ID: 35211419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
    Lu T; Wang R; Cai H; Cui Y
    Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic axis of SNHG19/miR-137/TNFAIP1 modulates amyloid beta peptide 25-35-induced SH-SY5Y cytotoxicity.
    Li Y; Jin L; Wang F; Ren L; Pen R; Bo G; Wang L
    Epigenomics; 2022 Feb; 14(4):187-198. PubMed ID: 35170354
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction: Long non-coding RNA NEAT1 accelerates cell progression in cervical cancer by regulating the miR-889-3p/E2F7 axis through the activation of the PI3K/AKT pathway.
    Fisher L
    RSC Adv; 2021 Jan; 11(9):5025. PubMed ID: 35426981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4 [Retraction].
    Onco Targets Ther; 2024; 17():147-148. PubMed ID: 38420288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1307324. PubMed ID: 37927471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840152. PubMed ID: 35036360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction].
    Onco Targets Ther; 2023; 16():1013-1014. PubMed ID: 38047059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NEAT1 Promotes Proliferation, Migration and Invasion via Regulating miR-296-5p/CNN2 Axis in Hepatocellular Carcinoma Cells [Retraction].
    Onco Targets Ther; 2021; 14():5095-5096. PubMed ID: 34707367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PVT1 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer via Regulating miR-148/RAB34 Signal Axis [Retraction].
    Onco Targets Ther; 2023; 16():653-654. PubMed ID: 37551310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction Notice to: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.
    Chen X; Wang Z; Tong F; Dong X; Wu G; Zhang R
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102215. PubMed ID: 38784179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis.
    Yuan Y; Zhou X; Kang Y; Kuang H; Peng Q; Zhang B; Liu X; Zhang M
    Life Sci; 2021 Feb; 267():118955. PubMed ID: 33359669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNHG7 Contributes to the Progression of Non-Small-Cell Lung Cancer via the SNHG7/miR-181a-5p/E2F7 Axis.
    Wang L; Zhang L; Wang L
    Cancer Manag Res; 2020; 12():3211-3222. PubMed ID: 32440218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction].
    Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction].
    Onco Targets Ther; 2021; 14():2235. PubMed ID: 33833521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis [Retraction].
    Cancer Manag Res; 2024; 16():65-66. PubMed ID: 38282791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840086. PubMed ID: 35036359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.